Therapeutic RSK1 Targeting in Myelofibrosis
Washington University School of Medicine
Washington University School of Medicine
Incyte Corporation
Incyte Corporation
Fred Hutchinson Cancer Center
Stanford University
Incyte Corporation
Incyte Corporation
Dana-Farber Cancer Institute
Incyte Corporation
Prelude Therapeutics
City of Hope Medical Center